← Back to Search

Proof-of-concept trial for Brain Metastases (AIM 2 Trial)

N/A

Waitlist Available

Led By Ashlee R Loughan, PhD

Research Sponsored by Virginia Commonwealth University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

AIM 2 Trial Summary

This trial assesses how caregivers in neuro-oncology benefit from CALM therapy, adapting it to their needs.

Eligible Conditions

Cancer Brain Metastases
Neuro-Oncology
Caregiver

AIM 2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Evaluate suitability of the CALM intervention to the needs of caregivers in neuro-oncology by measuring caregiver satisfaction.

Evaluate suitability of the CALM intervention to the needs of caregivers in neuro-oncology by measuring caregivers' recommendations to the content and format of the intervention during an exit-interview.

AIM 2 Trial Design

1Treatment groups

Experimental Treatment

Group I: Proof-of-concept trialExperimental Treatment1 Intervention

Inform CALM adaptations for caregivers of patients with brain cancer.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Virginia Commonwealth UniversityLead Sponsor

697 Previous Clinical Trials

22,884,995 Total Patients Enrolled

American Psychological FoundationOTHER

18 Previous Clinical Trials

1,906 Total Patients Enrolled

Ashlee R Loughan, PhDPrincipal InvestigatorVirginia Commonwealth University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities for enrollment in this investigation?

"This investigation, which was initially listed on November 3rd 2022, is actively recruiting patients. Information hosted on clinicaltrials.gov confirms this to be true."

Answered by AI

What is the approximate participation level of this trial?

"Affirmative. The data accessible on clinicaltrials.gov implies that this medical trial is currently recruiting candidates, with the initial listing taking place on November 3rd 2022 and a subsequent update to follow thereafter. At present, there are 6 openings at 1 research site for patients wishing to participate in the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Forgotten Voices: Addressing Unmet Needs in Brain Tumor Caregivers

2022. "Forgotten Voices: Addressing Unmet Needs in Brain Tumor Caregivers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05590273.